Kathryn E. Plant

757 total citations
30 papers, 541 citations indexed

About

Kathryn E. Plant is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Kathryn E. Plant has authored 30 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in Kathryn E. Plant's work include Pharmacogenetics and Drug Metabolism (5 papers), Glutathione Transferases and Polymorphisms (4 papers) and RNA Research and Splicing (4 papers). Kathryn E. Plant is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Glutathione Transferases and Polymorphisms (4 papers) and RNA Research and Splicing (4 papers). Kathryn E. Plant collaborates with scholars based in United Kingdom, Malaysia and Saudi Arabia. Kathryn E. Plant's co-authors include Nick Plant, Nicholas Proudfoot, Samantha Routledge, Costas Ioannides, Daphnee S. Pushparajah, Frances Flinter, Peter M. Green, Agneta Oskarsson, Peter S. Goldfarb and David Vetrie and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Kathryn E. Plant

28 papers receiving 534 citations

Peers

Countries citing papers authored by Kathryn E. Plant

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Plant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Plant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Plant more than expected).

Fields of papers citing papers by Kathryn E. Plant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Plant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Plant. The network helps show where Kathryn E. Plant may publish in the future.

Co-authorship network of co-authors of Kathryn E. Plant

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Plant. A scholar is included among the top collaborators of Kathryn E. Plant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Plant. Kathryn E. Plant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	50 Improving nursing wellbeing in a paediatric intensive care unit (PICU) during the COVID-19 pandemic 2021 ·Kathryn E. Plant	0
2	Alkyladenine DNA glycosylase deficiency uncouples alkylation-induced strand break generation from PARP-1 activation and glycolysis inhibition 2020 ·Scientific Reports ·Fahad A. Alhumaydhi, Débora de Oliveira Lopes, Diana L. Bordin, Abdullah S. M. Aljohani, (unknown), Michael McNicholas, (unknown), (unknown), Izabel Vianna Villela, João Antônio Pêgas Henriques, Kathryn E. Plant, Ruan Elliott, Lisiane B. Meira	10
3	Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity 2015 ·Toxicology ·(unknown), (unknown), (unknown), Jonathan D. Johnston, Nick Plant, Kathryn E. Plant	15
4	The naturally occurring aliphatic isothiocyanates sulforaphane and erucin are weak agonists but potent non-competitive antagonists of the aryl hydrocarbon receptor 2012 ·Archives of Toxicology ·Ahmad Faizal Abdull Razis, (unknown), (unknown), (unknown), Renato Iori, Kathryn E. Plant, Nick Plant, Costas Ioannides	9
5	A PXR-Mediated Negative Feedback Loop Attenuates the Expression of CYP3A in Response to the PXR Agonist Pregnenalone-16α-Carbonitrile 2011 ·PLoS ONE ·(unknown), G. Gordon Gibson, Kathryn E. Plant, Mark J. Graham, Nick Plant	25
6	Phenethyl isothiocyanate, a naturally occurring phytochemical, is an antagonist of the aryl hydrocarbon receptor 2011 ·Molecular Nutrition & Food Research ·Ahmad Faizal Abdull Razis, (unknown), (unknown), Kathryn E. Plant, Nick Plant, Costas Ioannides	7
7	S24 Differentiated primary bronchial epithelial cell (pBECs), monocyte derived macrophages (MdMs) and monocyte derived dendritic cells (MODCs) transwell co-culture: Respiratory Syncytial Virus (RSV) infection of the apical and basolateral surfaces 2010 ·Thorax ·(unknown), Kathryn E. Plant, Mark L. Everard	1
8	The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1 2008 ·Toxicology and Applied Pharmacology ·Kathryn E. Plant, Elizabeth A. Anderson, (unknown), Richard C. D. Brown, Samuel C. Forster, (unknown), Nick J. Toms, G. Gordon Gibson, (unknown), Nick Plant	26
9	Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung 2008 ·Mutagenesis ·Daphnee S. Pushparajah, (unknown), Kathryn E. Plant, Nick Plant, Costas Ioannides	36
10	Differential response of human and rat epoxide hydrolase to polycyclic aromatic hydrocarbon exposure: Studies using precision-cut tissue slices 2008 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Daphnee S. Pushparajah, (unknown), Kathryn E. Plant, Nick Plant, Costas Ioannides	12
11	Transcriptional Regulation of the Human Pregnane-X Receptor 2006 ·Drug Metabolism Reviews ·G. Gordon Gibson, (unknown), Sihem Aouabdi, Kathryn E. Plant, Nick Plant	21
12	Transcriptomic and phylogenetic analysis of Kpna genes: a family of nuclear import factors modulated in xenobiotic-mediated liver growth 2006 ·Pharmacogenetics and Genomics ·Kathryn E. Plant, (unknown), G. Gordon Gibson, (unknown), Nick Plant	6
13	Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro 2006 ·Journal of Applied Toxicology ·Agneta Oskarsson, Erik Ullerås, Kathryn E. Plant, J. P. Hinson, Peter S. Goldfarb	60
14	Evaluation of the precision-cut liver and lung slice systems for the study of induction of CYP1, epoxide hydrolase and glutathione S-transferase activities 2006 ·Toxicology ·Daphnee S. Pushparajah, (unknown), Kathryn E. Plant, Nick Plant, Costas Ioannides	24
15	Evolution of the fatty acid-binding protein family: An ordered increase in gene number, correlating to more refined mechanisms of lipid processing 2006 ·Toxicology ·Kathryn E. Plant, Alfred E. Thumser, Nick Plant	1
16	Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growth 2003 ·Biochemical Pharmacology ·Sarah Crunkhorn, Kathryn E. Plant, (unknown), (unknown), (unknown), Peter G. Lord, Nick Plant	17
17	A novel G472R mutation in a Turkish family with X-linked Alport syndrome 2000 ·Pediatric Nephrology ·Rezan Topaloğlu, Kathryn E. Plant, Frances Flinter	0
18	Detection of mutations in COL4A5 in patients with Alport Syndrome 1999 ·Human Mutation ·Kathryn E. Plant, Peter M. Green, David Vetrie, Frances Flinter	49
19	Stimulation of RNA 3′ processing by flanking DNA in Xenopus oocytes 1998 ·Gene ·Kathryn E. Plant, Garry T. Morgan	1
20	Genes encoding isoforms of transcription elongation factor TFIIS in Xenopus and the use of multiple unusual RNA processing signals 1996 ·Nucleic Acids Research ·Kathryn E. Plant	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact